From a genomic risk model to clinical trial implementation in a learning health system: the ProGRESS Study

Jason L Vassy, Anna M Dornisch, Roshan Karunamuni, Michael Gatzen, Christopher J Kachulis, Niall J Lennon, Charles A Brunette, Morgan E Danowski, Richard L Hauger, Isla P Garraway, Adam S Kibel, Kyung Min Lee, Julie A Lynch, Kara N Maxwell, Brent S Rose, Craig C Teerlink, George J Xu, Sean E Hofherr, Katherine A Lafferty, Katie Larkin, Edyta Malolepsza, Candace J Patterson, Diana M Toledo, Jenny L Donovan, Freddie Hamdy, Richard M Martin, David E Neal, Emma L Turner, Ole A Andreassen, Anders M Dale, Ian G Mills, Jyotsna Batra, Judith Clements, Olivier Cussenot, Cezary Cybulski, Rosalind A Eeles, Jay H Fowke, Eli Marie Grindedal, Robert J Hamilton, Jasmine Lim, Yong-Jie Lu, Robert J MacInnis, Christiane Maier, Lorelei A Mucci, Luc Multigner, Susan L Neuhausen, Sune F Nielsen, Marie-Élise Parent, Jong Y Park, Gyorgy Petrovics, Anna Plym, Azad Razack, Barry S Rosenstein, Johanna Schleutker, Karina Dalsgaard Sørensen, Ruth C Travis, Ana Vega, Catharine M L West, Fredrik Wiklund, Wei Zheng, Profile Steering Committee, IMPACT Study Steering Committee and Collaborators, PRACTICAL Consortium, Million Veteran Program, Tyler M Seibert
doi: https://doi.org/10.1101/2024.11.03.24316516

Article Information

doi 
https://doi.org/10.1101/2024.11.03.24316516
History 
  • November 4, 2024.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license.

Author Information

  1. Jason L Vassy1,2,3,*,#,
  2. Anna M Dornisch4,*,
  3. Roshan Karunamuni4,5,
  4. Michael Gatzen6,
  5. Christopher J Kachulis6,7,
  6. Niall J Lennon6,7,
  7. Charles A Brunette1,2,
  8. Morgan E Danowski1,
  9. Richard L Hauger5,
  10. Isla P Garraway8,9,
  11. Adam S Kibel10,
  12. Kyung Min Lee11,
  13. Julie A Lynch11,
  14. Kara N Maxwell12,13,
  15. Brent S Rose5,4,
  16. Craig C Teerlink14,15,
  17. George J Xu5,4,
  18. Sean E Hofherr6,
  19. Katherine A Lafferty6,7,
  20. Katie Larkin6,7,
  21. Edyta Malolepsza6,7,
  22. Candace J Patterson6,7,
  23. Diana M Toledo6,7,
  24. Jenny L Donovan16,
  25. Freddie Hamdy17,
  26. Richard M Martin16,18,
  27. David E Neal17,19,20,
  28. Emma L Turner16,
  29. Ole A Andreassen21,
  30. Anders M Dale21,22,23,24,
  31. Ian G Mills17,
  32. Jyotsna Batra25,26,
  33. Judith Clements27,28,
  34. Olivier Cussenot29,30,
  35. Cezary Cybulski31,
  36. Rosalind A Eeles32,33,
  37. Jay H Fowke34,
  38. Eli Marie Grindedal35,
  39. Robert J Hamilton36,37,
  40. Jasmine Lim38,
  41. Yong-Jie Lu39,
  42. Robert J MacInnis40,41,
  43. Christiane Maier42,43,
  44. Lorelei A Mucci44,
  45. Luc Multigner45,
  46. Susan L Neuhausen46,
  47. Sune F Nielsen47,48,
  48. Marie-Élise Parent49,50,
  49. Jong Y Park51,
  50. Gyorgy Petrovics52,53,
  51. Anna Plym44,54,
  52. Azad Razack38,
  53. Barry S Rosenstein55,
  54. Johanna Schleutker56,57,
  55. Karina Dalsgaard Sørensen58,59,
  56. Ruth C Travis60,
  57. Ana Vega61,62,63,
  58. Catharine M L West64,
  59. Fredrik Wiklund54,
  60. Wei Zheng65,
  61. Profile Steering Committee,
  62. IMPACT Study Steering Committee and Collaborators,
  63. PRACTICAL Consortium,
  64. Million Veteran Program and
  65. Tyler M Seibert5,21,22,66,67,#
  1. 1VA Boston Healthcare System, Boston, MA, USA
  2. 2Department of Medicine, Harvard Medical School, Boston, MA, USA
  3. 3Division of General Internal Medicine and Primary Care, Brigham and Women’s Hospital, Boston, MA, USA
  4. 4Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, CA, USA
  5. 5Research Service, VA San Diego Healthcare System, San Diego, CA, USA
  6. 6Broad Institute of MIT and Harvard, Cambridge, MA, USA
  7. 7Broad Clinical Labs, Burlington, MA, USA
  8. 8Division of Urology, VA Greater Los Angeles Healthcare System, Los Angeles, CA, USA
  9. 9Department of Urology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA
  10. 10Urology Division, Department of Surgery, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA
  11. 11VA Informatics and Computing Infrastructure, VA Salt Lake City Healthcare System, Salt Lake City, UT, USA
  12. 12Corporal Michael Crescenz Veterans Affairs Medical Center, Philadelphia, PA, USA
  13. 13Department of Medicine – Hematology/Oncology, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA
  14. 14VA Salt Lake City Healthcare System, Salt Lake City, UT, USA
  15. 15Division of Epidemiology, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA
  16. 16Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK
  17. 17Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK
  18. 18NIHR Biomedical Research Centre at the University Hospitals Bristol and Weston NHS Foundation Trust and the University of Bristol, United Kingdom
  19. 19University of Cambridge, Department of Oncology, Cambridge, UK
  20. 20Cancer Research UK, Cambridge Research Institute, Cambridge, UK
  21. 21NORMENT, KG Jebsen Centre, Oslo University Hospital and University of Oslo, Oslo, Norway
  22. 22Department of Radiology, University of California San Diego, La Jolla, CA, USA
  23. 23Department of Neurosciences, University of California, San Diego, La Jolla, CA, USA
  24. 24Halicioglu Data Science Institute, University of California San Diego, La Jolla, CA, USA
  25. 25Australian Prostate Cancer Research Centre-Qld, Institute of Health and Biomedical Innovation and School of Biomedical Sciences, Queensland University of Technology, Brisbane, Australia
  26. 26Translational Research Institute, Brisbane, Australia
  27. 27Australian Prostate Cancer Research Centre-Qld, Queensland University of Technology, Brisbane; Prostate Cancer Research Program, Monash University, Melbourne; Dame Roma Mitchell Cancer Centre, University of Adelaide, Adelaide; Chris O’Brien Lifehouse and The Kinghorn Cancer Centre, Sydney, Australia
  28. 28Translational Research Institute, Brisbane, Queensland, Australia
  29. 29Sorbonne Universite, Paris, France
  30. 30Tenon Hospital, Paris, France
  31. 31International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland
  32. 32The Institute of Cancer Research, London, UK
  33. 33Royal Marsden NHS Foundation Trust, London, UK
  34. 34Division of Epidemiology, Department of Preventive Medicine, University of Tennessee Health Science Center, Memphis, TN
  35. 35Department of Medical Genetics, Oslo University Hospital, 0424 Oslo, Norway
  36. 36Dept. of Surgical Oncology, Princess Margaret Cancer Centre, Toronto, Canada
  37. 37Dept. of Surgery (Urology), University of Toronto, Canada
  38. 38Department of Surgery, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
  39. 39Centre for Cancer Biomarker and Biotherapeutics, Barts Cancer Institute, Queen Mary University of London, London, UK
  40. 40Cancer Epidemiology Division, Cancer Council Victoria, East Melbourne, Australia
  41. 41Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Parkville, Australia
  42. 42Zentrum für Humangenetik Tuebingen, Tuebingen, Germany
  43. 43Institut für Humangenetik, University of Ulm, Germany
  44. 44Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, MA, USA
  45. 45Univ Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail), Rennes, France
  46. 46Department of Population Sciences, Beckman Research Institute of the City of Hope, Duarte, CA, USA
  47. 47Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Copenhagen, Denmark
  48. 48Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
  49. 49Epidemiology and Biostatistics Unit, Centre Armand-Frappier Santé Biotechnologie, Institut national de la recherche scientifique, Laval, QC, Canada
  50. 50Department of Social and Preventive Medicine, School of Public Health, University of Montreal, Montreal, QC, Canada
  51. 51Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL, USA
  52. 52Uniformed Services University, Bethesda, MD, USA
  53. 53Center for Prostate Disease Research, Bethesda, MD, USA
  54. 54Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden
  55. 55Department of Radiation Oncology and Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA
  56. 56Institute of Biomedicine, University of Turku, Finland
  57. 57Department of Medical Genetics, Genomics, Laboratory Division, Turku University Hospital, Turku, Finland
  58. 58Department of Molecular Medicine, Aarhus University Hospital, Aarhus N, Denmark
  59. 59Department of Clinical Medicine, Aarhus University, Aarhus N, Denmark
  60. 60Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK
  61. 61Fundación Pública Galega Medicina Xenómica, Santiago de Compostela, Spain
  62. 62Instituto de Investigación Sanitaria de Santiago de Compostela, Santiago De Compostela, Spain
  63. 63Centro de Investigación en Red de Enfermedades Raras (CIBERER), Spain
  64. 64Division of Cancer Sciences, University of Manchester, Manchester Academic Health Science Centre, Radiotherapy Related Research, The Christie Hospital NHS Foundation Trust, Manchester, UK
  65. 65Division of Epidemiology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA
  66. 66Department of Urology, University of California San Diego, La Jolla, CA, USA
  67. 67Department of Bioengineering, University of California San Diego, La Jolla, CA, USA
  1. ↵#Correspondence: Jason L. Vassy (jvassy{at}bwh.harvard.edu) and Tyler M. Seibert (tseibert{at}health.ucsd.edu)

  1. ↵* These authors contributed equally

Back to top
Posted November 04, 2024.
Download PDF

Supplementary Material

Data/Code
Email
From a genomic risk model to clinical trial implementation in a learning health system: the ProGRESS Study
Jason L Vassy, Anna M Dornisch, Roshan Karunamuni, Michael Gatzen, Christopher J Kachulis, Niall J Lennon, Charles A Brunette, Morgan E Danowski, Richard L Hauger, Isla P Garraway, Adam S Kibel, Kyung Min Lee, Julie A Lynch, Kara N Maxwell, Brent S Rose, Craig C Teerlink, George J Xu, Sean E Hofherr, Katherine A Lafferty, Katie Larkin, Edyta Malolepsza, Candace J Patterson, Diana M Toledo, Jenny L Donovan, Freddie Hamdy, Richard M Martin, David E Neal, Emma L Turner, Ole A Andreassen, Anders M Dale, Ian G Mills, Jyotsna Batra, Judith Clements, Olivier Cussenot, Cezary Cybulski, Rosalind A Eeles, Jay H Fowke, Eli Marie Grindedal, Robert J Hamilton, Jasmine Lim, Yong-Jie Lu, Robert J MacInnis, Christiane Maier, Lorelei A Mucci, Luc Multigner, Susan L Neuhausen, Sune F Nielsen, Marie-Élise Parent, Jong Y Park, Gyorgy Petrovics, Anna Plym, Azad Razack, Barry S Rosenstein, Johanna Schleutker, Karina Dalsgaard Sørensen, Ruth C Travis, Ana Vega, Catharine M L West, Fredrik Wiklund, Wei Zheng, Profile Steering Committee, IMPACT Study Steering Committee and Collaborators, PRACTICAL Consortium, Million Veteran Program, Tyler M Seibert
medRxiv 2024.11.03.24316516; doi: https://doi.org/10.1101/2024.11.03.24316516
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area